NCT02277613View on ClinicalTrials.gov

A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction

PHASE2TerminatedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

June 30, 2019

Study Completion Date

January 31, 2020

Conditions
Heart AttackNSTEMI
Interventions
BIOLOGICAL

AMI MultiStem cells

AMI MultiStem cells administration in coronary artery with a micro-infusion catheter.

OTHER

Sham

Sham procedure using Micro-Infusion Catheter in coronary artery without injection.

Trial Locations (11)

33614

Tampa

Unknown

Birmingham

Huntsville

Los Angeles

Clearwater

Gainesville

Detroit

Akron

Pittsburgh

Salt Lake City

Madison

Sponsors

Lead Sponsor

Healios K.K.
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Healios K.K.

INDUSTRY

NCT02277613 - A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction | Biotech Hunter | Biotech Hunter